Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Julian Druce and Leon Caly.
Julian Druce
Connection Strength
0.664
Leon Caly
  1. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 06; 178:104787.
    View in: PubMed
    Score: 0.219
  2. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med J Aust. 2020 06; 212(10):459-462.
    View in: PubMed
    Score: 0.219
  3. SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse. Nat Microbiol. 2021 07; 6(7):821-823.
    View in: PubMed
    Score: 0.060
  4. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. J Gen Virol. 2020 09; 101(9):925-940.
    View in: PubMed
    Score: 0.056
  5. Tracking the COVID-19 pandemic in Australia using genomics. Nat Commun. 2020 09 01; 11(1):4376.
    View in: PubMed
    Score: 0.056
  6. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020 04; 26(4):453-455.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.